SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused - 雷速官方网站

Author
Written by David Thompson
Published 2026-10-25
Viewed 5 min read
Dynamic Portfolio
            
            App Development C - 雷速 Dynamic Portfolio
            
            App Development C - 雷速

Sodium-glucose cotransporter 2 (SGLT2) inhibitors were associated with lower risks of kidney and cardiovascular (CV) events in older adults with type 2 diabetes (T2D), including those who are frail, according to a real-world analysis from South Korea... [5616 chars]

Post a comment

雷速